Communiqués Supernus Pharmaceuticals, Inc.

Actions

SUPN

US8684591089

Produits pharmaceutiques

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 31/07/2026			Varia. 5j.	Varia. 1 janv.
44,63 ^USD	-2,15%		-3,40%	-10,20%

13/05	Transcript : Supernus Pharmaceuticals, Inc. Presents at Bank of America Global Healthcare Conference 2026, May-12-2026 03:40 PM
06/05	Transcript : Supernus Pharmaceuticals, Inc., Q1 2026 Earnings Call, May 05, 2026

Communiqués

22/07	Supernus Pharmaceuticals to Announce Second Quarter 2026 Financial Results and Host Conference Call on August 4, 2026	GL
14/07	Supernus Celebrates Five-Year Anniversary of Qelbree® FDA Approval, Continuing to Deliver on Real-World Experience in ADHD	GL
27/05	Supernus Pharmaceuticals to Participate in June Investor Conferences	GL
06/05	Supernus Pharmaceuticals to Participate in the Bank of America 2026 Health Care Conference	GL
06/05	Supernus Pharmaceuticals : Quarterly Report for Quarter Ending March 31, 2026 (Form 10-Q)	PU
05/05	Supernus: Q1 Earnings Snapshot	AQ
05/05	Supernus Announces First Quarter 2026 Financial Results	GL
05/05	Supernus Announces First Quarter 2026 Financial Results	AQ
22/04	Supernus Pharmaceuticals to Announce First Quarter 2026 Financial Results and Host Conference Call on May 5, 2026	GL
24/02	Supernus: Q4 Earnings Snapshot	AQ
24/02	Supernus Announces Record Fourth Quarter and Full Year 2025 Financial Results	GL
24/02	Supernus Pharmaceuticals to Participate in March Investor Conferences	GL
12/02	Supernus Pharmaceuticals to Announce Fourth Quarter and Full Year 2025 Financial Results and Host Conference Call on February 24, 2026	GL
03/12	Supernus Pharmaceuticals to Participate in the Bank of America Securities 2025 CNS Therapeutics Virtual Conference	GL
21/11	Supernus Pharmaceuticals to Participate in the Piper Sandler 37th Annual Healthcare Conference	GL
12/11	Supernus to Participate in the 2025 Jefferies Global Healthcare Conference in London	GL
04/11	Supernus: Q3 Earnings Snapshot	AQ
04/11	Supernus Announces Third Quarter 2025 Financial Results	GL
21/10/25	Supernus Pharmaceuticals to Announce Third Quarter 2025 Financial Results and Host Conference Call on November 4, 2025	GL
27/08/25	Supernus Pharmaceuticals to Participate in September Investor Conferences	GL
05/08/25	Supernus: Q2 Earnings Snapshot	AQ
05/08/25	Supernus Announces Second Quarter 2025 Financial Results	GL
31/07/25	Supernus Pharmaceuticals Completes Acquisition of Sage Therapeutics	GL
28/07/25	Supernus Pharmaceuticals Announces Expiration of Hart-Scott-Rodino Waiting Period for Sage Therapeutics, Inc. Tender Offer	GL
22/07/25	Supernus Pharmaceuticals to Announce Second Quarter 2025 Financial Results and Host Conference Call and Webcast on August 5, 2025	GL